Bottom line
PRHSX vs FACDX: the short answer
PRHSX (T. Rowe Price Health Sciences Fund, Inc.) and FACDX (Fidelity Advisor Health Care Fund) share a meaningful slice of their top holdings — about 47% by weight.
PRHSX is cheaper at 0.83% vs 0.96% — a difference of $13 a year per $10,000 invested.
Over five years, PRHSX returned +4.2% a year vs +2.3% for FACDX (reporting dates differ).
Updated Nov 19, 2026
PRHSX vs FACDX side by side
| PRHSX | FACDX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | T. Rowe Price | Fidelity |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.83% | 0.96% |
| Annual cost per $10k | $83 | $96 |
| 10-yr cost on $10k (prospectus) | $1,025 | $1,685 |
| Max front load | — | — |
| 12b-1 fee | — | 0.25% |
| 1-yr return | +17.7% | +7.7% |
| 5-yr return (annualized) | +4.2% | +2.3% |
| 10-yr return (annualized) | +9.1% | +7.6% |
| Best quarter | +23.5% | +21.3% |
| Worst quarter | −15.8% | −15.0% |
| Net assets (fund) | $11.9B | $3.1B |
| Number of holdings | 279 | 154 |
| Portfolio turnover | 62% | 74% |
| Returns as of | Dec 31, 2025 | Sep 30, 2026 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | PRHSX | FACDX | Difference |
|---|---|---|---|
| 2025 | +17.7% | +14.2% | +3.5% |
| 2024 | +1.8% | +3.9% | −2.1% |
| 2023 | +3.1% | +3.8% | −0.7% |
| 2022 | −12.2% | −13.1% | +0.9% |
| 2021 | +13.3% | +11.2% | +2.1% |
| 2020 | +30.1% | +21.1% | +9.0% |
| 2019 | +29.1% | +27.9% | +1.2% |
| 2018 | +1.2% | +7.3% | −6.1% |
| 2017 | +28.0% | +24.1% | +3.9% |
| 2016 | −10.4% | −10.3% | −0.0% |
Source: Fund prospectus bar charts
Holdings overlap
11 of PRHSX's top 25 holdings also appear in FACDX's top 25.
| Holding | PRHSX | FACDX |
|---|---|---|
| Eli Lilly & Co | 14.28% | 7.66% |
| Johnson & Johnson | 6.63% | 3.78% |
| Unitedhealth Group Inc | 5.99% | 4.17% |
| Abbvie Inc | 5.10% | 3.62% |
| Merck & Co. Inc. | 4.01% | 2.09% |
| Gilead Sciences Inc | 2.82% | 1.25% |
| Thermo Fisher Scientific Inc | 2.52% | 6.31% |
| Natera Inc | 1.44% | 1.65% |
| Danaher Corp | 1.43% | 6.75% |
| Guardant Health Inc | 1.23% | 1.48% |
| Cvs Health Corp | 0.94% | 1.29% |
Source: SEC Form N-PORT
PRHSX top 10
- Eli Lilly & Co — 14.28%
- Johnson & Johnson — 6.63%
- Unitedhealth Group Inc — 5.99%
- Abbvie Inc — 5.10%
- Merck & Co. Inc. — 4.01%
- Gilead Sciences Inc — 2.82%
- Thermo Fisher Scientific Inc — 2.52%
- Vertex Pharmaceuticals Inc — 2.28%
- Bristol-myers Squibb Co — 2.11%
- Abbott Laboratories — 1.89%
FACDX top 10
- ELI LILLY and CO — 7.66%
- Danaher Corp — 6.75%
- Thermo Fisher Scientific Inc — 6.31%
- Unitedhealth Group Inc — 4.17%
- JOHNSON and JOHNSON — 3.78%
- Abbvie Inc — 3.62%
- Fidelity Revere Street Trust — 2.54%
- Argenx Se — 2.09%
- MERCK and CO INC — 2.09%
- West Pharmaceutical Svcs Inc — 2.06%
FAQ
What is the difference between PRHSX and FACDX?
Which is cheaper, PRHSX or FACDX?
Should I own both PRHSX and FACDX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.